chr12-110914159-G-GACAC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_000432.4(MYL2):c.274+23_274+26dupGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000407 in 1,376,718 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0016 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00026 ( 1 hom. )
Consequence
MYL2
NM_000432.4 intron
NM_000432.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.360
Publications
2 publications found
Genes affected
MYL2 (HGNC:7583): (myosin light chain 2) This gene encodes a major sarcomeric protein in mammalian striated muscle. The encoded protein plays a role in embryonic heart muscle structure and function, while phosphorylation of the encoded protein is involved in cardiac myosin cycling kinetics, torsion and function in adults. Mutations in this gene are associated with hypertrophic cardiomyopathy 10 and infant-onset myopathy. [provided by RefSeq, May 2022]
MYL2 Gene-Disease associations (from GenCC):
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 10Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- congenital fiber-type disproportion myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 12-110914159-G-GACAC is Benign according to our data. Variant chr12-110914159-G-GACAC is described in ClinVar as Benign. ClinVar VariationId is 1329421.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00161 (241/150138) while in subpopulation AFR AF = 0.00532 (218/40974). AF 95% confidence interval is 0.00474. There are 2 homozygotes in GnomAd4. There are 118 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYL2 | NM_000432.4 | c.274+23_274+26dupGTGT | intron_variant | Intron 4 of 6 | ENST00000228841.15 | NP_000423.2 | ||
| MYL2 | NM_001406745.1 | c.232+23_232+26dupGTGT | intron_variant | Intron 3 of 5 | NP_001393674.1 | |||
| MYL2 | NM_001406916.1 | c.217+23_217+26dupGTGT | intron_variant | Intron 4 of 6 | NP_001393845.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00155 AC: 233AN: 150034Hom.: 2 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
233
AN:
150034
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00107 AC: 125AN: 116462 AF XY: 0.000976 show subpopulations
GnomAD2 exomes
AF:
AC:
125
AN:
116462
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000260 AC: 319AN: 1226580Hom.: 1 Cov.: 16 AF XY: 0.000269 AC XY: 166AN XY: 617332 show subpopulations
GnomAD4 exome
AF:
AC:
319
AN:
1226580
Hom.:
Cov.:
16
AF XY:
AC XY:
166
AN XY:
617332
show subpopulations
African (AFR)
AF:
AC:
140
AN:
28500
American (AMR)
AF:
AC:
9
AN:
41470
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
23398
East Asian (EAS)
AF:
AC:
1
AN:
36664
South Asian (SAS)
AF:
AC:
35
AN:
78058
European-Finnish (FIN)
AF:
AC:
2
AN:
49598
Middle Eastern (MID)
AF:
AC:
0
AN:
5180
European-Non Finnish (NFE)
AF:
AC:
117
AN:
911954
Other (OTH)
AF:
AC:
14
AN:
51758
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.409
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00161 AC: 241AN: 150138Hom.: 2 Cov.: 31 AF XY: 0.00161 AC XY: 118AN XY: 73214 show subpopulations
GnomAD4 genome
AF:
AC:
241
AN:
150138
Hom.:
Cov.:
31
AF XY:
AC XY:
118
AN XY:
73214
show subpopulations
African (AFR)
AF:
AC:
218
AN:
40974
American (AMR)
AF:
AC:
8
AN:
15036
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3444
East Asian (EAS)
AF:
AC:
0
AN:
5144
South Asian (SAS)
AF:
AC:
4
AN:
4728
European-Finnish (FIN)
AF:
AC:
0
AN:
10196
Middle Eastern (MID)
AF:
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
AC:
10
AN:
67350
Other (OTH)
AF:
AC:
1
AN:
2068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
12
24
36
48
60
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cardiomyopathy Benign:1
Sep 30, 2020
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.